FIELD: biotechnology.
SUBSTANCE: gene cassette is developed targeting the genes of the influenza virus of A(H1N1) and A(H3N2) subtypes and B, HA, M1 and NA types, which encode proteins of the influenza virus.
EFFECT: cassette is intended for the subsequent production of a plasmid vector for the transduction of mammalian cells later used to create cell-producers of virus-like particles (VLP) of the influenza virus.
7 cl, 34 dwg, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FLU VIRUS PROTEINS PRODUCER MDCK CELL (OPTIONS) | 2018 |
|
RU2681482C1 |
| INFLUENZA VIRUS THE VIRUS-LIKE PARTICLE AND ITS OBTAINING METHOD | 2018 |
|
RU2681439C1 |
| LENTIVIRUS PLASMIDA (OPTIONS), METHOD FOR ITS OBTAINING (OPTIONS), SET OF PRIMERS FOR OBTAINING LENTIVIRUS PLASMID VECTOR (OPTIONS) | 2018 |
|
RU2680537C1 |
| METHOD OF PRODUCING A POLYVALENT INFLUENZA VACCINE | 2018 |
|
RU2701953C1 |
| MULTIVALENT INFLUENZA VACCINE | 2018 |
|
RU2706191C1 |
| CONCENTRATE OF INFLUENZA VACCINE AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2706544C1 |
| METHOD OF CONTROLLING PRODUCTION OF A VACCINE AGAINST INFLUENZA | 2018 |
|
RU2701959C1 |
| STRAIN OF BACTERIA ESCHERICHIA COLI - PRODUCER OF RECOMBINANT PROTEIN NS1 | 2021 |
|
RU2789735C1 |
| INFLUENZA VIRUS STRAIN INFLUBACT-H7/PSPA FOR THE PRODUCTION OF A COMBINED VACCINE AGAINST INFLUENZA A VIRUS AND BACTERIAL PNEUMONIA CAUSED BY STREPTOCOCCUS PNEUMONIAE | 2021 |
|
RU2776196C1 |
| EFFECTIVE INFLUENZA VLPS | 2004 |
|
RU2369405C2 |
